INFU
InfuSystem Holdings, Inc. AMEX$10.39
Mkt Cap $209.8M
52w Low $4.67
89.8% of range
52w High $11.04
50d MA $9.60
200d MA $9.15
P/E (TTM)
32.4x
EV/EBITDA
7.4x
P/B
3.7x
Debt/Equity
0.1x
ROE
11.6%
P/FCF
7.8x
RSI (14)
—
ATR (14)
—
Beta
1.55
50d MA
$9.60
200d MA
$9.15
Avg Volume
120.0K
About
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpa…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 24, 2026 | AMC | 0.07 | 0.10 | +42.9% | 8.60 | +1.2% | -0.5% | +6.9% | +2.0% | +8.0% | +6.7% | — |
| Nov 4, 2025 | AMC | 0.08 | 0.11 | +37.5% | 9.46 | +1.0% | +5.7% | +8.8% | +4.9% | +6.7% | +10.5% | — |
| Aug 5, 2025 | AMC | 0.03 | 0.12 | +300.0% | 6.07 | +2.1% | +18.1% | +23.9% | +45.5% | +41.7% | +55.4% | — |
| May 8, 2025 | AMC | -0.03 | -0.01 | +66.7% | 5.47 | -0.2% | -1.8% | +0.2% | +5.1% | +4.8% | +9.7% | — |
| Mar 4, 2025 | AMC | 0.08 | 0.04 | -50.0% | 6.47 | +1.9% | -3.7% | -3.4% | -5.6% | -12.8% | -13.9% | — |
| Nov 7, 2024 | AMC | 0.06 | 0.08 | +33.3% | 7.34 | -0.1% | +6.4% | +23.4% | +29.6% | +21.7% | +22.2% | — |
| Aug 8, 2024 | AMC | 0.04 | 0.03 | -18.3% | 6.00 | +0.3% | +0.0% | +0.0% | +11.0% | +12.8% | +10.3% | — |
| May 9, 2024 | AMC | -0.01 | -0.05 | -350.1% | 7.56 | -0.4% | -3.7% | -7.9% | -8.9% | -11.5% | -16.1% | — |
| Mar 14, 2024 | AMC | 0.00 | 0.00 | +0.0% | 9.02 | -0.4% | +2.9% | -1.1% | -2.0% | -1.6% | -0.3% | — |
| Nov 7, 2023 | AMC | 0.03 | 0.03 | +20.0% | 9.15 | -1.2% | -5.5% | -6.0% | -6.1% | -3.8% | +1.6% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 25 | Roth Capital | Maintains | Buy → Buy | — | $8.60 | $8.70 | +1.2% | -0.5% | +6.9% | +2.0% | +8.0% | +6.7% |
| Nov 5 | Roth Capital | Maintains | Buy → Buy | — | $9.46 | $9.55 | +1.0% | +5.7% | +8.8% | +4.9% | +6.7% | +10.5% |
| Apr 26 | Northland Capital Markets | Maintains | Outperform → Outperform | — | $22.27 | $22.80 | +2.4% | -0.3% | +0.9% | +1.6% | +2.2% | +1.6% |
| Aug 31 | Craig-Hallum | Maintains | Buy → Buy | — | $14.13 | $14.99 | +6.1% | +3.0% | -0.6% | -0.8% | -2.1% | -4.2% |
Recent Filings
8-K · 4.01
!!! Very High
Unknown — 8-K 4.01: Auditor Change / Resignation
Deloitte's resignation as INFU's auditor suggests potential accounting disputes or internal control concerns, creating uncertainty about financial reliability and potentially triggering stock volatility until a replacement auditor is appointed.
Mar 19
8-K · 7.01
! Medium
Unknown — 8-K 7.01: Regulation FD Disclosure
InfuSystem's conference participation announcement signals management confidence in the business outlook and provides an investor relations opportunity to discuss strategy, potentially supporting or stabilizing stock sentiment near the event date.
Mar 16
8-K · 7.01
! Medium
InfuSystem Holdings, Inc. -- 8-K 7.01: Regulation FD Disclosure
InfuSystem disclosed material information through Regulation FD, suggesting the company wants to ensure all investors receive information simultaneously, which could signal either positive developments or proactive transparency management that may affect stock valuation.
Feb 27
8-K
InfuSystem Holdings, Inc. -- 8-K Filing
InfuSystem Holdings achieved seventh consecutive year of record revenues at $143.4 million with net income surging 183% to $6.6 million and adjusted EBITDA reaching $31.5 million, demonstrating strong operational profitability and cash generation.
Feb 24
8-K · 7.01
! Medium
InfuSystem Holdings, Inc. -- 8-K 7.01: Regulation FD Disclosure
InfuSystem Holdings will hold a February 24, 2026 investor conference call to discuss company updates, providing shareholders direct access to management guidance and financial performance insights.
Feb 17
Data updated apr 25, 2026 3:35pm
· Source: massive.com